Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
Manufacturing Gaps in the U.S. Pharmaceutical Industry Exposed by Tariff Wars
Read More
white-paper
Assessing Animal-Derived Raw Materials for Viral Risk
Read More
post
What is Fast-Track Designation? Accelerating Life-Saving Drug Development
Read More
post
The Strategic Role of Regulatory Affairs in the Pharmaceutical Industry
Read More
Let's move from science to success.
Let’s Talk